OTHER
Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study.
Watanabe S, Kitagawa Y, Uchiyama A, Oishi Y, Tanaka H, Ishikawa G, Watanabe S, Suzuki E, Watanabe K, Matsushita Y, Watanabe H, Tamura K, Matsumoto R, Motoyama D, Nagata M, Inamoto T
- Year
- 2025
- Journal
- Central European journal of urology
Keywords
enfortumab vedotinurothelial carcinomareal-world studyefficacy
Related papers
OTHER
📊 26,957 cites
Statistical Learning Theory
Yuhai Wu, Vladimir Vapnik
1999
OTHER
Open access📊 20,501 cites
Fractional Differential Equations
Igor Podlubný
2025
OTHER
📊 18,993 cites
Applied Nonlinear Control
Jean-Jacques Slotine, Weiping Li
1991
OTHER
📊 13,277 cites
Genetic Programming: On the Programming of Computers by Means of Natural Selection
John R. Koza
1992